Search hospitals > New Mexico > Las Cruces
Memorial Medical Center - Las Cruces
Claim this profileLas Cruces, New Mexico 88011
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
108 reported clinical trials
13 medical researchers
Summary
Memorial Medical Center - Las Cruces is a medical facility located in Las Cruces, New Mexico. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Memorial Medical Center - Las Cruces is involved with conducting 108 clinical trials across 282 conditions. There are 13 research doctors associated with this hospital, such as Atul Kumar, Ursa A. Brown-Glaberman, Carolyn Y. Muller, and Neda Hashemi Sadraei.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Atul KumarUniversity of New Mexico Cancer Center4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
38 drugs studied
Ursa A. Brown-GlabermanUniversity of New Mexico Cancer Center4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
18 reported clinical trials
42 drugs studied
Carolyn Y. MullerUniversity of New Mexico Cancer Center1 year of reported clinical research
Studies Cancer
Studies Endometrial Cancer
19 reported clinical trials
39 drugs studied
Neda Hashemi SadraeiUniversity of New Mexico Cancer Center4 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
14 reported clinical trials
40 drugs studied
Clinical Trials running at Memorial Medical Center - Las Cruces
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Laryngeal Cancer
Squamous Cell Carcinoma
Colorectal Cancer
Oropharyngeal Carcinoma
Oral Squamous Cell Carcinoma
Hypopharyngeal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Imlunestrant
for Early Breast Cancer
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and must have a higher-than-average risk for their cancer to return. Study participation could last up to 10 years.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Memorial Medical Center - Las Cruces?
Memorial Medical Center - Las Cruces is a medical facility located in Las Cruces, New Mexico. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Memorial Medical Center - Las Cruces is involved with conducting 108 clinical trials across 282 conditions. There are 13 research doctors associated with this hospital, such as Atul Kumar, Ursa A. Brown-Glaberman, Carolyn Y. Muller, and Neda Hashemi Sadraei.